Why is Evoq Remedies falling/rising?

As of 10-Sep, Evoq Remedies Ltd is currently priced at 3.77, reflecting a decrease of 0.09 or 2.33%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 5.75% during this period. Despite a slight increase in investor participation, with delivery volume rising by 5.26% against the 5-day average, the stock's performance over the past month shows a decline of 2.33%, and a significant drop of 51.67% year-to-date. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.06% over the past week, Evoq Remedies has outperformed with a return of 2.72%. However, over the longer term, the stock has significantly lagged behind the benchmark, with a year-to-date decline of 51.67% compared to the Sensex's gain of 4.21%. This stark contrast highlights the challenges faced by Evoq Remedies in the current market environment, contributing to its recent price decline.